Concord Biotech Limited — Important, 25-03-2025: Commencement of commercial production/operations

Concord Biotech Limited has announced a board meeting on the commencement of commercial production at its new manufacturing facility, Unit-4, located in Valthera. The facility is designed to meet stringent international standards and aims to deliver high-quality injectable products. This milestone reflects the company’s commitment to its strategic growth initiatives. The operational launch is likely to enhance production capabilities, potentially boosting revenue streams and reinforcing investor confidence in Concord Biotech's expansion plans, indicating a positive outlook for future performance.